CYTOKINETICS, INCORPORATED Net Income
CYTOKINETICS, INCORPORATED (CYTK) reported Net Income of -$198.76 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$198.76M.
- CYTOKINETICS, INCORPORATED net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$206.03M.
- CYTOKINETICS, INCORPORATED net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$183.03M.
- CYTOKINETICS, INCORPORATED net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$306.18M.
- CYTOKINETICS, INCORPORATED net income (loss) attributable to parent for fiscal 2020 was -$127.29M.
- CYTOKINETICS, INCORPORATED net income (loss) attributable to parent for fiscal 2019 was -$121.69M.
- CYTOKINETICS, INCORPORATED net income (loss) attributable to parent for fiscal 2018 was -$106.29M.
- CYTOKINETICS, INCORPORATED net income (loss) attributable to parent for fiscal 2017 was -$127.79M, a 876.70% decline from fiscal 2016.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 17 month | Net Income (Loss) Attributable to Parent 167 month | Net Income (Loss) Attributable to Parent 170 month | Net Income (Loss) Attributable to Parent 173 month | Net Income (Loss) Attributable to Parent 176 month | Net Income (Loss) Attributable to Parent 179 month | Net Income (Loss) Attributable to Parent 182 month | Net Income (Loss) Attributable to Parent 185 month | Net Income (Loss) Attributable to Parent 188 month | Net Income (Loss) Attributable to Parent 191 month | Net Income (Loss) Attributable to Parent 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$198.76M 10-Q · filed 2026-08-06 | -$404.79M 10-Q · filed 2026-08-06 | -$587.82M derived: sum of 3 quarters · filed 2026-08-06 | -$894.00M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2026-03-31 | -$206.03M 10-Q · filed 2026-08-06 | -$389.06M derived: sum of 2 quarters · filed 2026-08-06 | -$695.24M derived: sum of 3 quarters · filed 2026-08-06 | -$829.61M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-12-31 | -$183.03M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-17 | -$489.21M derived: sum of 2 quarters · filed 2026-04-17 | -$623.58M derived: sum of 3 quarters · filed 2026-08-06 | -$784.96M DEF 14A · filed 2026-04-17 | |||||||||||||
| 2025-09-30 | -$306.18M 10-Q · filed 2025-11-05 | -$440.55M derived: sum of 2 quarters · filed 2026-08-06 | -$601.92M 10-Q · filed 2025-11-05 | -$751.94M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-06-30 | -$134.37M 10-Q · filed 2026-08-06 | -$295.75M 10-Q · filed 2026-08-06 | -$445.77M derived: sum of 3 quarters · filed 2026-08-06 | -$606.31M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-03-31 | -$161.38M 10-Q · filed 2026-08-06 | -$311.40M derived: sum of 2 quarters · filed 2026-08-06 | -$471.94M derived: sum of 3 quarters · filed 2026-08-06 | -$615.26M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2024-12-31 | -$150.02M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-17 | -$310.56M derived: sum of 2 quarters · filed 2026-04-17 | -$453.88M derived: sum of 3 quarters · filed 2026-04-17 | -$589.53M DEF 14A · filed 2026-04-17 | |||||||||||||
| 2024-09-30 | -$160.54M 10-Q · filed 2025-11-05 | -$303.86M derived: sum of 2 quarters · filed 2025-11-05 | -$439.51M 10-Q · filed 2025-11-05 | -$576.40M derived: sum of 4 quarters · filed 2026-04-17 | |||||||||||||
| 2024-06-30 | -$143.32M 10-Q · filed 2025-11-05 | -$278.96M 10-Q · filed 2025-08-07 | -$415.86M derived: sum of 3 quarters · filed 2026-04-17 | -$545.28M derived: sum of 4 quarters · filed 2026-04-17 | |||||||||||||
| 2024-03-31 | -$135.64M 10-Q · filed 2025-11-05 | -$272.54M derived: sum of 2 quarters · filed 2026-04-17 | -$401.96M derived: sum of 3 quarters · filed 2026-04-17 | -$530.60M derived: sum of 4 quarters · filed 2026-04-17 | |||||||||||||
| 2023-12-31 | -$136.90M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-17 | -$266.32M derived: sum of 2 quarters · filed 2026-04-17 | -$394.95M derived: sum of 3 quarters · filed 2026-04-17 | -$526.24M DEF 14A · filed 2026-04-17 | |||||||||||||
| 2023-09-30 | -$129.42M 10-Q · filed 2024-11-07 | -$258.06M derived: sum of 2 quarters · filed 2024-11-07 | -$389.35M 10-Q · filed 2024-11-07 | -$526.73M derived: sum of 4 quarters · filed 2026-04-17 | |||||||||||||
| 2023-06-30 | -$128.64M 10-Q · filed 2024-11-07 | -$259.93M 10-Q · filed 2024-08-09 | -$397.31M derived: sum of 3 quarters · filed 2026-04-17 | -$539.62M derived: sum of 4 quarters · filed 2026-04-17 | |||||||||||||
| 2023-03-31 | -$131.29M 10-Q · filed 2024-11-07 | -$268.67M derived: sum of 2 quarters · filed 2026-04-17 | -$410.98M derived: sum of 3 quarters · filed 2026-04-17 | -$430.80M derived: sum of 4 quarters · filed 2026-04-17 | |||||||||||||
| 2022-12-31 | -$137.38M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-17 | -$279.69M derived: sum of 2 quarters · filed 2026-04-17 | -$299.51M derived: sum of 3 quarters · filed 2026-04-17 | -$388.95M DEF 14A · filed 2026-04-17 | |||||||||||||
| 2022-09-30 | -$142.31M 10-Q · filed 2023-11-03 | -$162.13M derived: sum of 2 quarters · filed 2023-11-03 | -$251.57M 10-Q · filed 2023-11-03 | -$282.14M derived: sum of 4 quarters · filed 2026-04-17 | |||||||||||||
| 2022-06-30 | -$19.82M 10-Q · filed 2023-11-03 | -$109.27M 10-Q · filed 2023-08-03 | -$139.84M derived: sum of 3 quarters · filed 2026-04-17 | -$215.92M derived: sum of 4 quarters · filed 2026-04-17 | |||||||||||||
| 2022-03-31 | -$89.44M 10-Q · filed 2023-11-03 | -$120.02M derived: sum of 2 quarters · filed 2026-04-17 | -$196.10M derived: sum of 3 quarters · filed 2026-04-17 | -$257.65M derived: sum of 4 quarters · filed 2026-04-17 | |||||||||||||
| 2021-12-31 | -$30.57M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-17 | -$106.66M derived: sum of 2 quarters · filed 2026-04-17 | -$168.21M derived: sum of 3 quarters · filed 2026-04-17 | -$215.31M DEF 14A · filed 2026-04-17 | |||||||||||||
| 2021-09-30 | -$76.09M 10-Q · filed 2022-11-04 | -$137.64M derived: sum of 2 quarters · filed 2022-11-04 | -$184.74M 10-Q · filed 2022-11-04 | -$228.67M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||||
| 2021-06-30 | -$61.55M 10-Q · filed 2022-11-04 | -$108.66M 10-Q · filed 2022-08-05 | -$152.59M derived: sum of 3 quarters · filed 2023-03-01 | -$155.76M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||||
| 2021-03-31 | -$47.10M 10-Q · filed 2022-11-04 | -$91.03M derived: sum of 2 quarters · filed 2023-03-01 | -$94.21M derived: sum of 3 quarters · filed 2023-03-01 | -$134.99M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||||
| 2020-12-31 | -$43.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$47.10M derived: sum of 2 quarters · filed 2023-03-01 | -$87.89M derived: sum of 3 quarters · filed 2023-03-01 | -$127.29M 10-K · filed 2023-03-01 | |||||||||||||
| 2020-09-30 | -$3.17M 10-Q · filed 2021-11-05 | -$43.95M derived: sum of 2 quarters · filed 2021-11-05 | -$83.36M 10-Q · filed 2021-11-05 | -$114.00M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||||||
| 2020-06-30 | -$40.78M 10-Q · filed 2021-11-05 | -$80.19M 10-Q · filed 2021-08-06 | -$110.83M derived: sum of 3 quarters · filed 2022-02-25 | -$140.40M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||||||
| 2020-03-31 | -$39.41M 10-Q · filed 2021-11-05 | -$70.05M derived: sum of 2 quarters · filed 2022-02-25 | -$99.62M derived: sum of 3 quarters · filed 2022-02-25 | -$131.73M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||||||
| 2019-12-31 | -$30.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$60.21M derived: sum of 2 quarters · filed 2022-02-25 | -$92.33M derived: sum of 3 quarters · filed 2022-02-25 | -$121.69M 10-K · filed 2022-02-25 | |||||||||||||
| 2019-09-30 | -$29.57M 10-Q · filed 2020-11-06 | -$61.69M derived: sum of 2 quarters · filed 2020-11-06 | -$91.05M 10-Q · filed 2020-11-06 | -$117.52M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||||||
| 2019-06-30 | -$32.11M 10-Q · filed 2020-11-06 | -$61.48M 10-Q · filed 2020-08-07 | -$87.95M derived: sum of 3 quarters · filed 2021-02-26 | -$109.96M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||||||
| 2019-03-31 | -$29.37M 10-Q · filed 2020-11-06 | -$55.83M derived: sum of 2 quarters · filed 2021-02-26 | -$77.85M derived: sum of 3 quarters · filed 2021-02-26 | -$105.37M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||||||
| 2018-12-31 | -$26.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$48.48M derived: sum of 2 quarters · filed 2021-02-26 | -$76.01M derived: sum of 3 quarters · filed 2021-02-26 | -$106.29M 10-K · filed 2021-02-26 | |||||||||||||
| 2018-09-30 | -$22.02M 10-Q · filed 2019-11-01 | -$49.54M derived: sum of 2 quarters · filed 2019-11-01 | -$79.82M 10-Q · filed 2019-11-01 | -$120.31M derived: sum of 4 quarters · filed 2019-11-01 | |||||||||||||
| 2018-06-30 | -$27.52M 10-Q · filed 2019-11-01 | -$57.80M 10-Q · filed 2019-08-09 | -$98.29M derived: sum of 3 quarters · filed 2019-11-01 | -$130.65M derived: sum of 4 quarters · filed 2019-11-01 | |||||||||||||
| 2018-03-31 | -$30.28M 10-Q · filed 2019-11-01 | -$70.77M derived: sum of 2 quarters · filed 2019-11-01 | -$103.12M derived: sum of 3 quarters · filed 2019-11-01 | -$132.20M derived: sum of 4 quarters · filed 2019-11-01 | |||||||||||||
| 2017-12-31 | -$40.48M 10-K · filed 2018-03-05 | -$72.84M derived: sum of 2 quarters · filed 2018-11-09 | -$101.92M derived: sum of 3 quarters · filed 2018-11-09 | -$127.79M 10-K · filed 2019-03-07 | |||||||||||||
| 2017-09-30 | -$32.36M 10-Q · filed 2018-11-09 | -$61.44M derived: sum of 2 quarters · filed 2018-11-09 | -$87.31M 10-Q · filed 2018-11-09 | -$80.15M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||||||
| 2017-06-30 | -$29.08M 10-Q · filed 2018-08-07 | -$54.95M 10-Q · filed 2018-08-07 | -$47.79M derived: sum of 3 quarters · filed 2018-08-07 | -$14.43M derived: sum of 4 quarters · filed 2018-08-07 | |||||||||||||
| 2017-03-31 | -$25.87M 10-Q · filed 2018-05-10 | -$18.71M derived: sum of 2 quarters · filed 2018-05-10 | $14.65M derived: sum of 3 quarters · filed 2018-05-10 | $3.04M derived: sum of 4 quarters · filed 2018-05-10 | |||||||||||||
| 2016-12-31 | $7.16M 10-K · filed 2018-03-05 | $40.52M derived: sum of 2 quarters · filed 2018-03-05 | $28.91M derived: sum of 3 quarters · filed 2018-03-05 | $16.45M 10-K · filed 2018-03-05 | |||||||||||||
| 2016-09-30 | $33.36M 10-K · filed 2018-03-05 | $31.89M 10-Q · filed 2016-11-03 | $21.75M derived: sum of 2 quarters · filed 2018-03-05 | $9.30M 10-Q · filed 2017-11-03 | $7.82M 10-Q · filed 2016-11-03 | $67.00K derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||
| 2016-06-30 | -$11.61M 10-K · filed 2018-03-05 | -$24.07M 10-Q · filed 2017-08-04 | -$33.30M derived: sum of 3 quarters · filed 2018-03-05 | -$42.14M derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||||
| 2016-03-31 | -$12.46M 10-K · filed 2018-03-05 | -$21.68M derived: sum of 2 quarters · filed 2018-03-05 | -$30.53M derived: sum of 3 quarters · filed 2018-03-05 | -$41.08M derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||||
| 2015-12-31 | -$9.23M 10-K · filed 2017-03-06 | -$18.08M derived: sum of 2 quarters · filed 2017-03-06 | -$28.63M derived: sum of 3 quarters · filed 2017-03-06 | -$37.50M 10-K · filed 2018-03-05 | |||||||||||||
| 2015-09-30 | -$8.85M 10-K · filed 2017-03-06 | -$19.40M derived: sum of 2 quarters · filed 2017-03-06 | -$28.27M 10-Q/A · filed 2016-12-15 | -$19.83M derived: sum of 4 quarters · filed 2017-03-06 | |||||||||||||
| 2015-06-30 | -$10.55M 10-K · filed 2017-03-06 | -$19.42M 10-Q · filed 2016-08-04 | -$10.98M derived: sum of 3 quarters · filed 2017-03-06 | -$16.95M derived: sum of 4 quarters · filed 2017-03-06 | |||||||||||||
| 2015-03-31 | -$8.87M 10-K · filed 2017-03-06 | -$429.00K derived: sum of 2 quarters · filed 2017-03-06 | -$6.40M derived: sum of 3 quarters · filed 2017-03-06 | -$14.77M derived: sum of 4 quarters · filed 2017-03-06 | |||||||||||||
| 2014-12-31 | $8.44M 10-K · filed 2016-03-03 | $2.47M derived: sum of 2 quarters · filed 2016-03-03 | -$5.90M derived: sum of 3 quarters · filed 2016-03-03 | -$14.65M 10-K · filed 2017-03-06 | |||||||||||||
| 2014-09-30 | -$5.97M 10-K · filed 2016-03-03 | -$14.35M derived: sum of 2 quarters · filed 2016-03-03 | -$23.09M 10-Q · filed 2015-11-05 | -$16.56M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||||
| 2014-06-30 | -$8.37M 10-K · filed 2016-03-03 | -$17.12M 10-Q · filed 2015-08-05 | -$10.59M derived: sum of 3 quarters · filed 2016-03-03 | -$23.18M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||||
| 2014-03-31 | -$8.74M 10-K · filed 2016-03-03 | -$2.21M derived: sum of 2 quarters · filed 2016-03-03 | -$14.80M derived: sum of 3 quarters · filed 2016-03-03 | -$29.84M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||||
| 2013-12-31 | $6.53M 10-K · filed 2015-03-06 | -$6.06M derived: sum of 2 quarters · filed 2015-03-06 | -$21.10M derived: sum of 3 quarters · filed 2015-03-06 | -$33.72M 10-K · filed 2016-03-03 | |||||||||||||
| 2013-09-30 | -$12.59M 10-K · filed 2015-03-06 | -$27.63M derived: sum of 2 quarters · filed 2015-03-06 | -$40.25M 10-Q · filed 2014-11-06 | -$51.70M derived: sum of 4 quarters · filed 2015-03-06 | -$489.13M 10-Q · filed 2013-11-06 | ||||||||||||
| 2013-06-30 | -$15.04M 10-K · filed 2015-03-06 | -$27.66M 10-Q · filed 2014-08-07 | -$39.12M derived: sum of 3 quarters · filed 2015-03-06 | -$49.16M derived: sum of 4 quarters · filed 2015-03-06 | -$476.54M 10-Q · filed 2013-08-07 | ||||||||||||
| 2013-03-31 | -$12.62M 10-K · filed 2015-03-06 | -$24.07M derived: sum of 2 quarters · filed 2015-03-06 | -$34.12M derived: sum of 3 quarters · filed 2015-03-06 | -$43.06M derived: sum of 4 quarters · filed 2015-03-06 | -$461.50M 10-Q · filed 2013-05-08 | ||||||||||||
| 2012-12-31 | -$11.46M 10-K · filed 2014-03-07 | -$21.50M derived: sum of 2 quarters · filed 2014-03-07 | -$30.44M derived: sum of 3 quarters · filed 2014-03-07 | -$40.37M 10-K · filed 2015-03-06 | -$448.88M 10-K · filed 2013-03-15 | ||||||||||||
| 2012-09-30 | -$10.04M 10-K · filed 2014-03-07 | -$18.99M derived: sum of 2 quarters · filed 2014-03-07 | -$28.91M 10-Q · filed 2013-11-06 | -$40.79M derived: sum of 4 quarters · filed 2014-03-07 | -$437.42M 10-Q · filed 2012-11-07 | ||||||||||||
| 2012-06-30 | -$8.94M 10-K · filed 2014-03-07 | -$18.87M 10-Q · filed 2013-08-07 | -$30.75M derived: sum of 3 quarters · filed 2014-03-07 | -$41.39M derived: sum of 4 quarters · filed 2014-03-07 | -$427.38M 10-Q · filed 2012-08-06 | ||||||||||||
| 2012-03-31 | -$9.93M 10-K · filed 2014-03-07 | -$21.80M derived: sum of 2 quarters · filed 2014-03-07 | -$32.44M derived: sum of 3 quarters · filed 2014-03-07 | -$46.08M derived: sum of 4 quarters · filed 2014-03-07 | -$418.44M 10-Q · filed 2012-05-04 | ||||||||||||
| 2011-12-31 | -$11.88M 10-K · filed 2013-03-15 | -$22.52M derived: sum of 2 quarters · filed 2013-03-15 | -$36.15M derived: sum of 3 quarters · filed 2013-03-15 | -$47.86M 10-K · filed 2014-03-07 | -$408.51M 10-K · filed 2012-03-13 | ||||||||||||
| 2011-09-30 | -$10.64M 10-K · filed 2013-03-15 | -$24.27M derived: sum of 2 quarters · filed 2013-03-15 | -$35.98M 10-Q · filed 2012-11-07 | -$47.60M derived: sum of 4 quarters · filed 2013-03-15 | -$396.63M 10-Q · filed 2011-11-04 | ||||||||||||
| 2011-06-30 | -$13.63M 10-K · filed 2013-03-15 | -$25.34M 10-Q · filed 2012-08-06 | -$36.96M derived: sum of 3 quarters · filed 2013-03-15 | -$49.30M derived: sum of 4 quarters · filed 2013-03-15 | -$385.99M 10-Q · filed 2011-08-04 | ||||||||||||
| 2011-03-31 | -$11.71M 10-K · filed 2013-03-15 | -$23.32M derived: sum of 2 quarters · filed 2013-03-15 | -$35.67M derived: sum of 3 quarters · filed 2013-03-15 | -$48.81M derived: sum of 4 quarters · filed 2013-03-15 | |||||||||||||
| 2010-12-31 | -$11.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$23.95M derived: sum of 2 quarters · filed 2013-03-15 | -$37.10M derived: sum of 3 quarters · filed 2013-03-15 | -$49.29M 10-K · filed 2013-03-15 | |||||||||||||
| 2010-09-30 | -$12.34M 10-Q · filed 2011-11-04 | -$25.48M derived: sum of 2 quarters · filed 2011-11-04 | -$37.67M 10-Q · filed 2011-11-04 | ||||||||||||||
| 2010-06-30 | -$13.14M 10-Q · filed 2011-08-04 | -$25.33M 10-Q · filed 2011-08-04 | |||||||||||||||
| 2009-12-31 | $24.54M 10-K · filed 2013-03-15 | ||||||||||||||||
| 2008-12-31 | -$56.37M 10-K · filed 2013-03-15 | ||||||||||||||||
| 2007-12-31 | -$48.89M 10-K · filed 2013-03-15 | ||||||||||||||||
| 2006-12-31 | -$57.12M 10-K · filed 2013-03-15 | ||||||||||||||||
| 2005-12-31 | -$42.25M 10-K · filed 2013-03-15 | ||||||||||||||||
| 2004-12-31 | -$37.20M 10-K · filed 2013-03-15 | ||||||||||||||||
| 2003-12-31 | -$32.69M 10-K · filed 2013-03-15 | ||||||||||||||||
| 2002-12-31 | -$23.08M 10-K · filed 2013-03-15 | ||||||||||||||||
| 2001-12-31 | -$15.87M 10-K · filed 2013-03-15 | ||||||||||||||||
| 2000-12-31 | -$13.08M 10-K · filed 2013-03-15 | ||||||||||||||||
| 1999-12-31 | -$7.34M 10-K · filed 2013-03-15 | ||||||||||||||||
| 1998-12-31 | -$2.02M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |